The inhibition or mutation of Phosphatase and tensin homolog (PTEN), a tumor suppressor, is associated with the activation of the AKT-PI3K-mTOR pathway, promoting the initiation and progression of HCC [50]. The gene discussed is PTEN; the disease is hepatocellular carcinoma.